Diuretic dosing in heart failure: more data are needed.
作者信息
De Vecchis Renato, Rigopoulos Angelos, Bigalke Boris, Manginas Athanassios, Tschöpe Carsten, Noutsias Michel
机构信息
Cardiology Unit, Presidio Sanitario Intermedio "Elena d'Aosta", via Cagnazzi 29, c.a.p, 80137, Napoli, Italy.
Department of Internal Medicine III, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Halle, Martin-Luther-University Halle, Ernst-Grube-Straße 40, D-06120, Halle (Saale), Germany.
出版信息
ESC Heart Fail. 2018 Aug;5(4):649-650. doi: 10.1002/ehf2.12229. Epub 2018 Mar 25.
Abstract
摘要
相似文献
1
Diuretic dosing in heart failure: more data are needed.心力衰竭中的利尿剂给药：需要更多数据。
ESC Heart Fail. 2018 Aug;5(4):649-650. doi: 10.1002/ehf2.12229. Epub 2018 Mar 25.
2
Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.袢利尿剂与噻嗪类利尿剂联合应用于失代偿性心力衰竭患者的安全性和有效性（CLOROTIC）试验的原理与设计：一项双盲、随机、安慰剂对照研究，以确定联合利尿剂治疗（袢利尿剂与噻嗪类利尿剂联合）对失代偿性心力衰竭患者的疗效。
J Card Fail. 2016 Jul;22(7):529-36. doi: 10.1016/j.cardfail.2015.11.003. Epub 2015 Nov 11.
3
Intermittent subcutaneous furosemide: parenteral diuretic rescue for hospice patients with congestive heart failure resistant to oral diuretic.间歇性皮下注射呋塞米：用于对口服利尿剂耐药的临终关怀充血性心力衰竭患者的肠外利尿剂抢救。
Am J Hosp Palliat Care. 2013 Dec;30(8):791-2. doi: 10.1177/1049909112465795. Epub 2012 Nov 6.
4
[Diuretic therapy in acute heart failure].[急性心力衰竭的利尿治疗]
Med Clin (Barc). 2014 Mar;142 Suppl 1:36-41. doi: 10.1016/S0025-7753(14)70081-8.
5
In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.在伴有明显液体潴留的慢性心力衰竭中，静脉注射大剂量袢利尿剂是肾功能恶化的一个预测指标，尤其是在左心室收缩功能正常或仅轻度受损的心力衰竭患者中。
Minerva Cardioangiol. 2011 Dec;59(6):543-54. Epub 2011 Feb 18.
6
Patterns of diuretic use in the intensive care unit.利尿剂在重症监护病房的使用模式。
PLoS One. 2019 May 31;14(5):e0217911. doi: 10.1371/journal.pone.0217911. eCollection 2019.
7
Pharmacotherapy in congestive heart failure: drug absorption in the management of congestive heart failure: loop diuretics.充血性心力衰竭的药物治疗：充血性心力衰竭管理中的药物吸收：袢利尿剂。
Congest Heart Fail. 2003 Sep-Oct;9(5):287-92. doi: 10.1111/j.1527-5299.2003.02399.x.
8
Can Torsemide and Combination of Loop Diuretics Improve Mortality in Patients with Chronic Heart Failure After Discharge?托拉塞米及襻利尿剂联合使用能否改善慢性心力衰竭患者出院后的死亡率？
Int Heart J. 2018 Jul 31;59(4):813-820. doi: 10.1536/ihj.17-522. Epub 2018 Jun 6.
9
Effect of timed semirecumbency and furosemide dosing on urinary sodium excretion in patients with compensated heart failure.
Am J Med Sci. 2006 Jul;332(1):1-5. doi: 10.1097/00000441-200607000-00001.
10
Reply: Readmissions and Diuretic Dosing.
JACC Heart Fail. 2017 Aug;5(8):618-619. doi: 10.1016/j.jchf.2017.06.003.
引用本文的文献
1
New treatments for hyperkalaemia: clinical use in cardiology.高钾血症的新疗法：在心脏病学中的临床应用
Eur Heart J Suppl. 2019 Feb;21(Suppl A):A41-A47. doi: 10.1093/eurheartj/suy031. Epub 2019 Feb 26.
本文引用的文献
1
The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure.出院时大剂量使用袢利尿剂与心力衰竭患者心血管死亡率的关系。
ESC Heart Fail. 2018 Feb;5(1):87-94. doi: 10.1002/ehf2.12221. Epub 2017 Oct 2.
2
The Efficacy and Safety of Tolvaptan in Patients with Hyponatremia: A Meta-Analysis of Randomized Controlled Trials.托伐普坦治疗低钠血症患者的疗效与安全性：随机对照试验的荟萃分析
Clin Drug Investig. 2017 Apr;37(4):327-342. doi: 10.1007/s40261-016-0470-3.
3
Diuretic Use and Risk of Vertebral Fracture in Women.女性利尿剂的使用与椎体骨折风险
Am J Med. 2016 Dec;129(12):1299-1306. doi: 10.1016/j.amjmed.2016.07.013. Epub 2016 Aug 16.
4
In right or biventricular chronic heart failure addition of thiazides to loop diuretics to achieve a sequential blockade of the nephron is associated with increased risk of dilutional hyponatremia: results of a case-control study.在右心或双心室慢性心力衰竭中，将噻嗪类药物添加到袢利尿剂中以实现对肾单位的序贯阻断，与稀释性低钠血症风险增加相关：一项病例对照研究的结果。
Minerva Cardioangiol. 2012 Oct;60(5):517-29.
5
Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.多巴胺输注对住院心力衰竭患者肾功能的影响：急性失代偿性心力衰竭（DAD-HF）试验的结果。
J Card Fail. 2010 Dec;16(12):922-30. doi: 10.1016/j.cardfail.2010.07.246.
6
Contemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspective.心力衰竭的药物和体外管理的当代趋势：肾脏学视角
Circulation. 2008 Feb 19;117(7):975-83. doi: 10.1161/CIRCULATIONAHA.107.742270.
Zotero 插件